The nuclear translocation of YAP1 and TAZ is associated with increased breast cancer progression, metastasis, epithelial-to-mesenchymal transition (EMT), epithelial stem cell regeneration, and therapeutic resistance [6]. This evidence concerns the gene YAP1 and breast carcinoma.